5-[(4-bromophenyl)sulfamoyl]-2-chlorobenzoic acid, 97%, 250mg

1-(6-Fluorobenzo[d]thiazol-2-yl)hydrazine, 95.0%, 25g

(S,S)-(+)-2,3-Bis(tert-butylmethylphosphino)quinoxaline>98.0%(HPLC)100mg

2,4-Difluoro-5-nitrobenzonitrile, 95.0%, 25g

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarboxylate, 95.0%, 1g

Citric acid, min. 99.5%, ultra pure, anhydrous, 5 kg, plastic packaging.

2-AMINO-2-(PYRAZIN-2-YL)ACETIC ACID, 95.0%, 250mg

2-(4-Methylcyclohex-3-en-1-yl)propan-2-ol, 95.0%, 100g

3-Bromo-4-(difluoromethoxy)pyridine, 96%, 250mg

2-Bromo-N-(piperidine-4-yl)benzamido hydrochloride, 95.0%, 1g

2-Tert-butyl-4-[(3-chlorophenyl)methylidene]-1,2,3,4-tetrahydroacridine-9-carboxylic acid, 95%, 100mg

Ethyl 5-chloro-7-methyl-1h-indole-2-carboxylate, 97%, 250mg

5-METHYL-2-(1H-1,2,3-TRIAZOL-1-YL)BENZOIC ACID, 95.0%, 250mg